VCP
WST icon

Verus Capital Partners’s West Pharmaceutical WST Stock Holding History

Verus Capital Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$40K Hold
261
– – 0.01% 568
2019
Q4 		$39K Buy
+261
New +$38K 0.01% 684

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Verus Capital Partners's WST Position: Q1 2020 in Review

Verus Capital Partners held its West Pharmaceutical (WST) position steady in Q1 2020 at 261 shares worth $40K. The position accounts for 0.01% of the portfolio, ranked #568.

Verus Capital Partners first reported a position in WST in Q4 2019 and has held it in 2 quarters since. 468 funds tracked by Wall St. Rank hold WST as of Q1 2020.

  • Verus Capital Partners held 261 shares of West Pharmaceutical worth $40K as of Q1 2020.
  • Verus Capital Partners left its West Pharmaceutical share count unchanged in Q1 2020.
  • West Pharmaceutical made up 0.01% of Verus Capital Partners's portfolio in Q1 2020, its #568 holding.
  • Verus Capital Partners first reported a position in West Pharmaceutical in Q4 2019 and has held it in 2 quarters since.
  • 468 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2020.

Based on Verus Capital Partners's 13F filing for Q1 2020, filed 26 May 2020.